Valuation: MRI Interventions Inc

Market Cap 423M 372M 347M 318M 598M 40.61B 605M 4.12B 1.61B 20.05B 1.59B 1.56B 69.31B P/E 2026 *
-12.7x
P/E 2027 * -15x
Enterprise Value 423M 372M 347M 318M 598M 40.61B 605M 4.12B 1.61B 20.05B 1.59B 1.56B 69.31B EV / Sales 2026 *
7.97x
EV / Sales 2027 * 6.61x
Free-Float
94.52%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 49 07/11/2017
Director of Finance/CFO 41 01/01/2021
Chief Tech/Sci/R&D Officer - 01/01/2026
Director TitleAgeSince
Director/Board Member 68 10/03/2014
Chairman 80 04/02/2021
Director/Board Member 49 07/11/2017
Change 5-day change 1-year change 3-year change Capi.($)
-5.04%-33.93% - - 423M
-1.54%+6.33%+15.38%-0.09% 211B
+2.61%-2.29%-3.17%-23.02% 135B
+5.73%+1.04%-27.76%+10.28% 119B
+2.85%+3.98%-57.00%-13.54% 65.77B
+0.50%-2.31%+5.80%+0.45% 47.58B
+1.43%+1.25%-25.87%-31.67% 44.44B
-0.49%+5.86%+15.35%+8.87% 39.14B
-0.93%+3.82%+22.77%+30.15% 36.79B
-2.38%+2.59%+72.43%-0.12% 29.37B
Average +0.35%+0.67%+1.99%-2.08% 80.9B
Weighted average by Cap. +1.31%+0.78%-2.13%-3.73%

Financials

2026 *2027 *
Net sales 53.13M 46.71M 43.48M 39.93M 74.98M 5.1B 75.97M 517M 202M 2.52B 199M 195M 8.7B 64.1M 56.35M 52.45M 48.17M 90.46M 6.15B 91.65M 624M 244M 3.04B 241M 235M 10.49B
Net income -33.07M -29.07M -27.06M -24.85M -46.66M -3.17B -47.28M -322M -126M -1.57B -124M -121M -5.41B -28.63M -25.17M -23.43M -21.52M -40.41M -2.75B -40.94M -279M -109M -1.36B -107M -105M -4.69B
Net Debt - -
Logo MRI Interventions Inc
ClearPoint Neuro, Inc. is a commercial-stage medical device company that develops and commercializes integrated systems used in minimally invasive neurosurgical procedures in the brain. The Company provides clinical products and preclinical development services for controlled drug and device delivery. Its business consists of two components: a business providing medical devices for neurosurgical applications, and a business focused on partnerships in the biologics and drug delivery space. Its primary medical device product, the ClearPoint system, is an integrated system comprised of hardware components, disposable components, and intuitive, menu-driven software. The primary applications for the ClearPoint system are to target and guide the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, and the infusion of pharmaceuticals into the brain. It provides consulting services to its pharmaceutical and other medical technology partners.
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-